Genvor Incorporated (GNVR)
OTCMKTS · Delayed Price · Currency is USD
0.6600
-0.1900 (-22.35%)
Feb 19, 2026, 2:22 PM EST

Genvor Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Dec '21
Selling, General & Admin
1.535.952.541.360.80.65
Research & Development
0.450.460.240.080.010.23
Operating Expenses
1.986.412.781.444.523.1
Operating Income
-1.98-6.41-2.78-1.44-4.52-3.1
Interest Expense
-0.07-0.06-0.02-0.04-0.11-0.1
Other Non Operating Income (Expenses)
0.020.01-0---
EBT Excluding Unusual Items
-2.03-6.46-2.8-1.48-4.63-3.2
Merger & Restructuring Charges
------0.11
Other Unusual Items
0.870.87-0.08-0.23-0.13-0.12
Pretax Income
-1.16-5.59-2.88-1.71-4.75-3.44
Net Income
-1.16-5.59-2.88-1.71-4.75-3.44
Net Income to Common
-1.16-5.59-2.88-1.71-4.75-3.44
Shares Outstanding (Basic)
292620202922
Shares Outstanding (Diluted)
292620202922
Shares Change (YoY)
42.23%29.25%1.71%-33.36%30.39%218.63%
EPS (Basic)
-0.04-0.22-0.15-0.09-0.16-0.15
EPS (Diluted)
-0.04-0.22-0.15-0.09-0.16-0.15
Free Cash Flow
-0.75-0.56-0.98-0.86-0.78-0.66
Free Cash Flow Per Share
-0.03-0.02-0.05-0.04-0.03-0.03
EBITDA
-1.97-6.41-2.78-1.44-4.52-3.1
D&A For EBITDA
000000
EBIT
-1.98-6.41-2.78-1.44-4.52-3.1
Advertising Expenses
-00.08---
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.